Currently a strategic consultant providing commercial, clinical and go-to-market planning for a multi- billion-dollar brand, small start–up high growth biotechnology companies and health centers.
• Providing lifecycle management planning support for all aspects of development and execution (from Phase III through launch) of commercialization strategy
• Executing novel engagement programs for improving and driving clinical trial recruitment for Phase 2 and Phase 3 programs

Served as team leader for microbiome clinical research organization, with management responsibility for team of scientists and commercial professionals. Member of two-man project team for IND-ready planning and phase 1 clinical trial for small molecule.
• Responsible for the strategy for clinical trial client division, including product offering, GxP requirements and development of all governance structures of research service organization

Worked as managing consultant focused on strategic planning, product development, and reimbursement strategy and operations for pharmaceutical companies, and precision medicine companies. Example of project objectives include:
• Lead year-long commercial project team focused on XUS launch strategy, budget and communications plan for first-in-class ocular disease medication
• Strategic assessment of large oncology clinical trial program